Advisory Alpha’s Vertex Pharmaceuticals VRTX Stock Holding History

Advisory Alpha's VRTX Position: Q1 2026 in Review

Advisory Alpha reduced its Vertex Pharmaceuticals (VRTX) stake by 0.65% in Q1 2026, selling an estimated $6.06K and leaving 2,001 shares worth $894K. The position accounts for 0.02% of the portfolio, ranked #207.

Advisory Alpha first reported a position in VRTX in Q1 2019 and has held it in 14 quarters since. The position peaked at $913K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

• Advisory Alpha held 2,001 shares of Vertex Pharmaceuticals worth $894K as of Q1 2026.
• Advisory Alpha sold 13 Vertex Pharmaceuticals shares in Q1 2026, an estimated $6.06K.
• Vertex Pharmaceuticals made up 0.02% of Advisory Alpha's portfolio in Q1 2026, its #207 holding.
• Advisory Alpha first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 14 quarters since.
• Advisory Alpha's Vertex Pharmaceuticals position peaked at $913K in Q4 2025.
• 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.